| 摘要 |
A method of pharmaceutically managing snoring is provided by the instillatio n intranasally of a solution containing 1-20 % methylsulfonylmethane by weight dissolved in water so as to saturate the nasal mucous membranes. Preferably, the solution has between 10 %-16 % by weight methylsulfonylmethane. The solution may be buffered, and/or a mild analgesic may be included. The metho d prefers that instillation occur as close to the sleep event as possible, and it should be at least within one hour before a person retires for sleep. The solution may be introduced by spray or drop-wise, and a product packaging th e solution in a suitable container is described.
|
